ADVANTAGES OF PARTICIPATION

• Gain insights on lab design and fitting out trends from top speakers from around the world
• Network with industry experts and players from renowned international organizations

ACCREDITATION

This course is accredited by:

Board of Architects - Singapore Institute of Architects Continuing Professional Development Programme. Participants will be awarded 4 CPD points on completion of the course.

Professional Engineers Board Continuing Professional Development Programme - Participants will be awarded 12 PDUs on completion of the course.

FEES

$856 (price inclusive of 7% GST) per person for a 2 days seminar

APPLICATION DEADLINE
14 January 2009

WEBSITE

URL : http://www.one-north.sg/hubs_biopolis_seminar.aspx
 

ABOUT JTC CORPORATION

JTC Corporation (JTC) is the lead agency in Singapore to plan, promote and develop a dynamic industrial landscape, in support of the nation's economic advancement.  Currently, the Corporation has under its management many developments including four wafer fab parks, an advanced display park, two business parks, a chemicals hub at Jurong Island, biomedical parks in Tuas as well as logistics hubs for aerospace, chemical and general warehousing industries. 

JTC also plays a catalytic role in introducing leading-edge real estate solutions - such as specialized research facilities and underground caverns -- to anchor important activities critical to the growth of the economy.  It is the master developer for one-north at Buona Vista -- a 200-hectare development for research and entrepreneurial activities.  With a focus on knowledge-intensive activities in the biomedical, infocomms and media industries, one-north is a niche environment for innovation and creativity. 

In line with its vision of making Singapore the choice investment location, JTC is committed to providing a pro-business environment for its customers and optimizing land resources to meet the needs of industries and enterprises.  JTC's home page address is http://www.jtc.gov.sg.

ABOUT one-north

One-north is Singapore's icon of the knowledge economy. It serves to provide an intellectually stimulating and creative environment for entrepreneurs, scientists and researchers to congregate, interact and exchange ideas; an exceptional place where this thriving community will work, live, play and learn. With a focus on knowledge-intensive activities in the biomedical, infocomms and media industries, it is slated to be a vibrant hotspot for innovation and test bedding.

Covering almost 200 hectares, one-north will be developed in phases over a period of 15 to 20 years, integrating residential units, commercial hubs, tertiary and research institutes, sports facilities as well as green lungs. It is strategically located in the Buona Vista area (southern part of Singapore) near the National University of Singapore and Singapore Science Park and aims to be a focal point for research and development and technopreneurial activities.

One-north is developed through a multi-government agency effort under the guidance of the Steering Committee chaired by Minister Lim Swee Say. JTC Corporation was appointed master developer for this project in September 2000.

one-north's home page address on the World Wide Web is http://www.one-north.sg.

ABOUT BIOPOLIS

Biopolis is a purpose-built biomedical R&D hub at one-north. It is also the first major development in one-north.

The Biopolis, which houses public and private research agencies, aims to anchor the development of the entire research and development value chain of life sciences. Essentially, Biopolis sees research being taken from bench to bedside, where biomedical research will translate to patient care.  Basic and translational research, clinical trials and eventually healthcare delivery are all done at Biopolis. This fosters close links between the public and private research agencies by stimulating collaboration and cross-disciplinary research. It further acts as a catalyst in forging international links with renowned scientific institutions through research collaborations and graduate training partnerships.

Developed by JTC Corporation at a cost of S$500 million, Phase 1 of the Biopolis was officially opened in 2003. It comprises a cluster of seven buildings of 8 to 13 storeys high which are interconnected by sky bridges.  The names of the seven buildings reflect the building blocks of biomedical research - Proteos, Chromos, Centros, Matrix, Genome, Nanos and Helios. Two of the buildings, Chromos and Helios, are dedicated to biomedical players from the private sector. The other five house the public sector biomedical research institutes of the Agency for Science, Technology and Research (A*STAR), Singapore's lead agency for scientific research and development.  Biopolis Phase 1 is home to more than 2,000 scientists, researchers, technicians and administrators. The research community is fully supported by state-of-the-art infrastructure and services catering to the full spectrum of biomedical R&D activities. More than 95% of the space in Phase 1 has been taken up.

Phase 2 of the Biopolis was officially opened in 2006. Comprising two buildings (Neuros and Immunos), Phase 2 offers an additional 37,000 sqm of built-up area. More than 96% of the space in Phase 2 has been taken up.

Phase 3 of the Biopolis, a designated multi-tenanted biomedical research facility, broke ground on 2 April 2008. The project was awarded to Crescendas Group (the first private developer in the biomedical hub) under a design-build-own-operate tender. Comprising two buildings, measuring 41,505 sqm in Gross Floor Area, Biopolis Phase 3 is expected to be completed by early 2010.   It will tap on the synergies of the Biopolis cluster and support world-class research programmes in clinical and translational research as well as medical technology research.